Nov 25, 2013 8:30 am EST Heat Biologics Successfully Completes Manufacturing of HS-410 to Start Phase 1/2 Bladder Cancer Trial
Nov 14, 2013 9:20 am EST Heat Biologics, Inc. Reports Third Quarter 2013 Financial Results and Provides Clinical Programs Review
Sep 19, 2013 10:00 am EDT Heat Biologics, Inc. to Present at Aegis Capital Corp. 2013 Healthcare Conference
Sep 04, 2013 12:55 pm EDT Heat Biologics, Inc. Announces Partial Exercise of Underwriters' Over-Allotment Option
Aug 13, 2013 11:43 am EDT Heat Biologics, Inc. Announces Partial Exercise of Underwriters' Over-Allotment Option
Jul 29, 2013 12:00 pm EDT Heat Biologics, Inc. Announces Closing of Initial Public Offering of 2,500,000 Shares of Common Stock